-
1
-
-
84900992727
-
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
-
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014;60:1268-1289.
-
(2014)
J Hepatol
, vol.60
, pp. 1268-1289
-
-
Bridgewater, J.1
Galle, P.R.2
Khan, S.A.3
Llovet, J.M.4
Park, J.W.5
Patel, T.6
-
3
-
-
77649180424
-
Cholangiocarcinoma: update and future perspectives
-
Gatto M, Bragazzi MC, Semeraro R, Napoli C, Gentile R, Torrice A, et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 2010;42:253-260.
-
(2010)
Dig Liver Dis
, vol.42
, pp. 253-260
-
-
Gatto, M.1
Bragazzi, M.C.2
Semeraro, R.3
Napoli, C.4
Gentile, R.5
Torrice, A.6
-
4
-
-
79953705666
-
Cholangiocarcinoma-controversies and challenges
-
Patel T. Cholangiocarcinoma-controversies and challenges. Nat Rev Gastroenterol Hepatol 2011;8:189-200.
-
(2011)
Nat Rev Gastroenterol Hepatol
, vol.8
, pp. 189-200
-
-
Patel, T.1
-
5
-
-
84902786936
-
Cholangiocarcinoma
-
Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014;383:2168-2179.
-
(2014)
Lancet
, vol.383
, pp. 2168-2179
-
-
Razumilava, N.1
Gores, G.J.2
-
6
-
-
2942615272
-
The epidemiology of cholangiocarcinoma
-
Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-125.
-
(2004)
Semin Liver Dis
, vol.24
, pp. 115-125
-
-
Shaib, Y.1
El-Serag, H.B.2
-
7
-
-
84875237481
-
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies
-
Sia D, Tovar V, Moeini A, Llovet JM. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene 2013;32:4861-4870.
-
(2013)
Oncogene
, vol.32
, pp. 4861-4870
-
-
Sia, D.1
Tovar, V.2
Moeini, A.3
Llovet, J.M.4
-
8
-
-
0036056617
-
Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma
-
Tannapfel A, Sommerer F, Benicke M, et al. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol 2002;197:624-631.
-
(2002)
J Pathol
, vol.197
, pp. 624-631
-
-
Tannapfel, A.1
Sommerer, F.2
Benicke, M.3
-
9
-
-
0037624602
-
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
-
Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F, et al. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut 2003;52:706-712.
-
(2003)
Gut
, vol.52
, pp. 706-712
-
-
Tannapfel, A.1
Sommerer, F.2
Benicke, M.3
Weinans, L.4
Katalinic, A.5
Geissler, F.6
-
10
-
-
36549074631
-
YAP1 increases organ size and expands undifferentiated progenitor cells
-
Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007;17:2054-2060.
-
(2007)
Curr Biol
, vol.17
, pp. 2054-2060
-
-
Camargo, F.D.1
Gokhale, S.2
Johnnidis, J.B.3
Fu, D.4
Bell, G.W.5
Jaenisch, R.6
-
11
-
-
34548636132
-
Elucidation of a universal size-control mechanism in Drosophila and mammals
-
Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007;130:1120-1133.
-
(2007)
Cell
, vol.130
, pp. 1120-1133
-
-
Dong, J.1
Feldmann, G.2
Huang, J.3
Wu, S.4
Zhang, N.5
Comerford, S.A.6
-
12
-
-
77951837150
-
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
-
Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 2010;24:862-874.
-
(2010)
Genes Dev
, vol.24
, pp. 862-874
-
-
Zhao, B.1
Li, L.2
Lei, Q.3
Guan, K.L.4
-
13
-
-
79960997489
-
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
-
Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011;13:877-883.
-
(2011)
Nat Cell Biol
, vol.13
, pp. 877-883
-
-
Zhao, B.1
Tumaneng, K.2
Guan, K.L.3
-
14
-
-
84901774050
-
The Hippo signaling pathway in stem cell biology and cancer
-
Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep 2014;15:642-656.
-
(2014)
EMBO Rep
, vol.15
, pp. 642-656
-
-
Mo, J.S.1
Park, H.W.2
Guan, K.L.3
-
15
-
-
47549095853
-
TEAD mediates YAP-dependent gene induction and growth control
-
Zhao B, Ye X, Yu J, Li L, Li W, Li S, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008;22:1962-1971.
-
(2008)
Genes Dev
, vol.22
, pp. 1962-1971
-
-
Zhao, B.1
Ye, X.2
Yu, J.3
Li, L.4
Li, W.5
Li, S.6
-
16
-
-
84862605178
-
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
-
Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012;26:1300-1305.
-
(2012)
Genes Dev
, vol.26
, pp. 1300-1305
-
-
Liu-Chittenden, Y.1
Huang, B.2
Shim, J.S.3
Chen, Q.4
Lee, S.J.5
Anders, R.A.6
-
17
-
-
84879839350
-
The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences
-
Hau JC, Erdmann D, Mesrouze Y, Furet P, Fontana P, Zimmermann C, et al. The TEAD4-YAP/TAZ protein-protein interaction: expected similarities and unexpected differences. Chembiochem 2013;14:1218-1225.
-
(2013)
Chembiochem
, vol.14
, pp. 1218-1225
-
-
Hau, J.C.1
Erdmann, D.2
Mesrouze, Y.3
Furet, P.4
Fontana, P.5
Zimmermann, C.6
-
18
-
-
84921262679
-
The Hippo pathway in disease and therapy: cancer and beyond
-
Gomez M, Gomez V, Hergovich A. The Hippo pathway in disease and therapy: cancer and beyond. Clin Transl Med 2014;3:22.
-
(2014)
Clin Transl Med
, vol.3
, pp. 22
-
-
Gomez, M.1
Gomez, V.2
Hergovich, A.3
-
20
-
-
79957465561
-
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice
-
Kowalik MA, Saliba C, Pibiri M, Perra A, Ledda-Columbano GM, Sarotto I, et al. Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice. Hepatology 2011;53:2086-2096.
-
(2011)
Hepatology
, vol.53
, pp. 2086-2096
-
-
Kowalik, M.A.1
Saliba, C.2
Pibiri, M.3
Perra, A.4
Ledda-Columbano, G.M.5
Sarotto, I.6
-
21
-
-
84930204654
-
YAP activation is an early event and a potential therapeutic target in liver cancer development
-
Perra A, Kowalik MA, Ghiso E, Ledda-Columbano GM, Di Tommaso L, Angioni MM, et al. YAP activation is an early event and a potential therapeutic target in liver cancer development. J Hepatol 2014;61:1088-1096.
-
(2014)
J Hepatol
, vol.61
, pp. 1088-1096
-
-
Perra, A.1
Kowalik, M.A.2
Ghiso, E.3
Ledda-Columbano, G.M.4
Di Tommaso, L.5
Angioni, M.M.6
-
22
-
-
84882746359
-
Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis
-
Piccolo S, Cordenonsi M, Dupont S. Molecular pathways: YAP and TAZ take center stage in organ growth and tumorigenesis. Clin Cancer Res 2013;19:4925-4930.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 4925-4930
-
-
Piccolo, S.1
Cordenonsi, M.2
Dupont, S.3
-
23
-
-
79952298459
-
Yap1 acts downstream of alpha-catenin to control epidermal proliferation
-
Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011;144:782-795.
-
(2011)
Cell
, vol.144
, pp. 782-795
-
-
Schlegelmilch, K.1
Mohseni, M.2
Kirak, O.3
Pruszak, J.4
Rodriguez, J.R.5
Zhou, D.6
-
24
-
-
84878273791
-
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma
-
Tschaharganeh DF, Chen X, Latzko P, Malz M, Gaida MM, Felix K, et al. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma. Gastroenterology 2013;144:1530-1542.
-
(2013)
Gastroenterology
, vol.144
, pp. 1530-1542
-
-
Tschaharganeh, D.F.1
Chen, X.2
Latzko, P.3
Malz, M.4
Gaida, M.M.5
Felix, K.6
-
25
-
-
54049121368
-
Yes-associated protein (YAP) functions as a tumor suppressor in breast
-
Yuan M, Tomlinson V, Lara R, Holliday D, Chelala C, Harada T, et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ 2008;15:1752-1759.
-
(2008)
Cell Death Differ
, vol.15
, pp. 1752-1759
-
-
Yuan, M.1
Tomlinson, V.2
Lara, R.3
Holliday, D.4
Chelala, C.5
Harada, T.6
-
26
-
-
84871789026
-
Restriction of intestinal stem cell expansion and the regenerative response by YAP
-
Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2013;493:106-110.
-
(2013)
Nature
, vol.493
, pp. 106-110
-
-
Barry, E.R.1
Morikawa, T.2
Butler, B.L.3
Shrestha, K.4
de la Rosa, R.5
Yan, K.S.6
-
27
-
-
84906934146
-
Activation of beta catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice
-
Tao J, Calvisi DF, Ranganathan S, Cigliano A, Zhou L, Singh S, et al. Activation of beta catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 2014;147:690-701.
-
(2014)
Gastroenterology
, vol.147
, pp. 690-701
-
-
Tao, J.1
Calvisi, D.F.2
Ranganathan, S.3
Cigliano, A.4
Zhou, L.5
Singh, S.6
-
28
-
-
77952336576
-
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
-
Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010;107:8248-8253.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 8248-8253
-
-
Lee, K.P.1
Lee, J.H.2
Kim, T.S.3
Kim, T.H.4
Park, H.D.5
Byun, J.S.6
-
29
-
-
76549124517
-
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
-
Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010;107:1437-1442.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 1437-1442
-
-
Lu, L.1
Li, Y.2
Kim, S.M.3
Bossuyt, W.4
Liu, P.5
Qiu, Q.6
-
30
-
-
84903783722
-
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation
-
Li J, Razumilava N, Gores GJ, Walters S, Mizuochi T, Mourya R, et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 2014;124:3241-3251.
-
(2014)
J Clin Invest
, vol.124
, pp. 3241-3251
-
-
Li, J.1
Razumilava, N.2
Gores, G.J.3
Walters, S.4
Mizuochi, T.5
Mourya, R.6
-
31
-
-
55249122446
-
Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas
-
Karamitopoulou E, Tornillo L, Zlobec I, Cioccari L, Carafa V, Borner M, et al. Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. Am J Clin Pathol 2008;130:780-786.
-
(2008)
Am J Clin Pathol
, vol.130
, pp. 780-786
-
-
Karamitopoulou, E.1
Tornillo, L.2
Zlobec, I.3
Cioccari, L.4
Carafa, V.5
Borner, M.6
-
32
-
-
84876145364
-
Constitutive Notch2 signaling induces hepatic tumors in mice
-
Dill MT, Tornillo L, Fritzius T, Terracciano L, Semela D, Bettler B, et al. Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology 2013;57:1607-1619.
-
(2013)
Hepatology
, vol.57
, pp. 1607-1619
-
-
Dill, M.T.1
Tornillo, L.2
Fritzius, T.3
Terracciano, L.4
Semela, D.5
Bettler, B.6
-
33
-
-
34047116826
-
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
-
Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007;39:457-466.
-
(2007)
Nat Genet
, vol.39
, pp. 457-466
-
-
Weber, M.1
Hellmann, I.2
Stadler, M.B.3
Ramos, L.4
Pääbo, S.5
Rebhan, M.6
-
34
-
-
84859169877
-
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
-
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012;483:603-607.
-
(2012)
Nature
, vol.483
, pp. 603-607
-
-
Barretina, J.1
Caponigro, G.2
Stransky, N.3
Venkatesan, K.4
Margolin, A.A.5
Kim, S.6
-
35
-
-
34547871639
-
GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor
-
Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 2007;23:1846-1847.
-
(2007)
Bioinformatics
, vol.23
, pp. 1846-1847
-
-
Davis, S.1
Meltzer, P.S.2
-
36
-
-
84889262099
-
Thymic epithelial cell expansion through matricellular protein CYR61 boosts progenitor homing and T-cell output
-
Emre Y, Irla M, Dunand-Sauthier I, Ballet R, Meguenani M, Jemelin S, et al. Thymic epithelial cell expansion through matricellular protein CYR61 boosts progenitor homing and T-cell output. Nat Commun 2013;4:2842.
-
(2013)
Nat Commun
, vol.4
, pp. 2842
-
-
Emre, Y.1
Irla, M.2
Dunand-Sauthier, I.3
Ballet, R.4
Meguenani, M.5
Jemelin, S.6
-
37
-
-
18144380288
-
Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation
-
Grotendorst GR, Duncan MR. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 2005;19:729-738.
-
(2005)
FASEB J
, vol.19
, pp. 729-738
-
-
Grotendorst, G.R.1
Duncan, M.R.2
-
38
-
-
70749118578
-
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2
-
Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK, et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell 2009;16:521-532.
-
(2009)
Cancer Cell
, vol.16
, pp. 521-532
-
-
Mok, S.C.1
Bonome, T.2
Vathipadiekal, V.3
Bell, A.4
Johnson, M.E.5
Wong, K.K.6
-
39
-
-
0346792725
-
TRAIL and apoptosis induction by TNF-family death receptors
-
Wang S, El-Deiry WS. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 2003;22:8628-8633.
-
(2003)
Oncogene
, vol.22
, pp. 8628-8633
-
-
Wang, S.1
El-Deiry, W.S.2
-
40
-
-
38949199337
-
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function
-
Lau LM, Nugent JK, Zhao X, Irwin MS . HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function. Oncogene 2008;27:997-1003.
-
(2008)
Oncogene
, vol.27
, pp. 997-1003
-
-
Lau, L.M.1
Nugent, J.K.2
Zhao, X.3
Irwin, M.S.4
-
41
-
-
84859441690
-
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors
-
Andersen JB, Spee B, Blechacz BR, Avital I, Komuta M, Barbour A, et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 2012;142:1021-1031.
-
(2012)
Gastroenterology
, vol.142
, pp. 1021-1031
-
-
Andersen, J.B.1
Spee, B.2
Blechacz, B.R.3
Avital, I.4
Komuta, M.5
Barbour, A.6
-
42
-
-
84878362932
-
G13 controls angiogenesis through regulation of VEGFR-2 expression
-
Sivaraj KK, Takefuji M, Schmidt I, Adams RH, Offermanns S, Wettschrueck N. G13 controls angiogenesis through regulation of VEGFR-2 expression. Dev Cell 2013;25:427-434.
-
(2013)
Dev Cell
, vol.25
, pp. 427-434
-
-
Sivaraj, K.K.1
Takefuji, M.2
Schmidt, I.3
Adams, R.H.4
Offermanns, S.5
Wettschrueck, N.6
-
43
-
-
84880948836
-
Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration
-
Nolan DJ, Ginsberg M, Israely E, Palikuqi B, Poulos MG, James D, et al. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev Cell 2013;26:204-219.
-
(2013)
Dev Cell
, vol.26
, pp. 204-219
-
-
Nolan, D.J.1
Ginsberg, M.2
Israely, E.3
Palikuqi, B.4
Poulos, M.G.5
James, D.6
-
44
-
-
0037249343
-
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
-
Basu S, Totty NF, Irwin MS, Sudol M, Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003;11:11-23.
-
(2003)
Mol Cell
, vol.11
, pp. 11-23
-
-
Basu, S.1
Totty, N.F.2
Irwin, M.S.3
Sudol, M.4
Downward, J.5
-
45
-
-
38949123978
-
Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage
-
Levy D, Adamovich Y, Reuven N, Shaul Y. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 2008;29:350-361.
-
(2008)
Mol Cell
, vol.29
, pp. 350-361
-
-
Levy, D.1
Adamovich, Y.2
Reuven, N.3
Shaul, Y.4
-
46
-
-
70350502865
-
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene
-
Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009;16:425-438.
-
(2009)
Cancer Cell
, vol.16
, pp. 425-438
-
-
Zhou, D.1
Conrad, C.2
Xia, F.3
Park, J.S.4
Payer, B.5
Yin, Y.6
-
47
-
-
84877930326
-
The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development
-
Barry ER, Camargo FD. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development. Curr Opin Cell Biol 2013;25:247-253.
-
(2013)
Curr Opin Cell Biol
, vol.25
, pp. 247-253
-
-
Barry, E.R.1
Camargo, F.D.2
-
48
-
-
84887208062
-
The hippo tumor suppressor network: from organ size control to stem cells and cancer
-
Halder G, Camargo FD. The hippo tumor suppressor network: from organ size control to stem cells and cancer. Cancer Res 2013;73:6389-6392.
-
(2013)
Cancer Res
, vol.73
, pp. 6389-6392
-
-
Halder, G.1
Camargo, F.D.2
-
49
-
-
84902081616
-
Hippo pathway activity influences liver cell fate
-
Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, et al. Hippo pathway activity influences liver cell fate. Cell 2014;157:1324-1338.
-
(2014)
Cell
, vol.157
, pp. 1324-1338
-
-
Yimlamai, D.1
Christodoulou, C.2
Galli, G.G.3
Yanger, K.4
Pepe-Mooney, B.5
Gurung, B.6
-
50
-
-
84875244110
-
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes
-
Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 2013;144:829-840.
-
(2013)
Gastroenterology
, vol.144
, pp. 829-840
-
-
Sia, D.1
Hoshida, Y.2
Villanueva, A.3
Roayaie, S.4
Ferrer, J.5
Tabak, B.6
|